Stay updated on Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.

Latest updates to the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedUpdate the ClinicalTrials.gov page revision/version indicator from **v3.5.2** to **v3.5.3**, reflecting a site-level release rather than a modification to the study’s documented information.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry v3.4.2 has been added to the study record history, and the v3.4.1 entry has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history shows an added Revision: v3.4.1 and a removed Revision: v3.4.0, reflecting a small system update.SummaryDifference0.1%

Stay in the know with updates to Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.